|
1
|
Bevacizumab inhibits corneal neovascularization in an alkali burn induced model of corneal angiogenesis.
|
Clin Experiment Ophthalmol
|
2007
|
1.64
|
|
2
|
A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
|
Med Hypotheses
|
2006
|
1.00
|
|
3
|
Bevacizumab (Avastin) as a potential novel adjunct in the management of pterygia.
|
Med Hypotheses
|
2007
|
0.94
|
|
4
|
Comparative study of Gram stain, potassium hydroxide smear, culture and nested PCR in the diagnosis of fungal keratitis.
|
Ophthalmic Res
|
2010
|
0.93
|
|
5
|
Anti-VEGF therapy with bevacizumab for anterior segment eye disease.
|
Cornea
|
2012
|
0.84
|
|
6
|
Detection of Aspergillus keratitis in ocular infections by culture and molecular method.
|
Int Ophthalmol
|
2011
|
0.79
|